AtriCure Q3 adjusted EPS $0.18 versus estimate of -$0.05
ATRC•AtriCure reported Q3 adjusted EPS of $0.18, revenue of $154.5 million and adjusted EBITDA of $26.8 million. It forecast full-year revenue of $606 million to $610 million and adjusted EBITDA of $91 million to $94 million.
1. Quarterly results
AtriCure reported Q3 revenue of $154.5 million versus the $151.2 million estimate, operating income of $4.4 million, gross margin of 77.3% and gross profit of $119.4 million. Adjusted EBITDA was $26.8 million, compared with the $19.6 million estimate.
2. Full-year outlook
AtriCure forecast full-year revenue of $606 million to $610 million, versus the $606.2 million estimate, and adjusted EBITDA of $91 million to $94 million, versus the $87.5 million estimate.
